Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Melinta Therapeutics

    Client Virtual Booth

    MELINTA THERAPEUTICS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Melinta Therapeutics
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    6663, 300 George St #301, New Haven, CT 06511, United States
    Telephone
    Telephone
    +1 844‑633‑6568
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://melinta.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/melinta-therapeutics/
    Twitter
    Twitter
    https://twitter.com/MelintaTx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Venatorx and Melinta Provide Update on Status of NDA for Cefepime-Taniborbactam
    Venatorx and Melinta Provide Update on Status of NDA for Cefepime-Taniborbactam

    https://www.businesswire.com/news/home/20240223169844/en

    BUSINESSWIRE
    23 Feb 2024
    Share Share
    Melinta & Cidara Announce Publication of Pooled Data from Phase 3 of REZZAYO
    Melinta & Cidara Announce Publication of Pooled Data from Phase 3 of REZZAYO

    https://www.businesswire.com/news/home/20231205775801/en

    BUSINESSWIRE
    05 Dec 2023
    Share Share
    Melinta Therapeutics and Venatorx Pharmaceuticals Announce Licensing Agreement
    Melinta Therapeutics and Venatorx Pharmaceuticals Announce Licensing Agreement

    https://www.businesswire.com/news/home/20231109219250/en

    BUSINESSWIRE
    09 Nov 2023
    Share Share
    Melinta Announces Presentations of Data on Infectious Disease Portfolio
    Melinta Announces Presentations of Data on Infectious Disease Portfolio

    https://www.businesswire.com/news/home/20231011988241/en

    BUSINESSWIRE
    11 Oct 2023
    Share Share
    Melinta Announces Expanded Reimbursement and Access for REZZAYO
    Melinta Announces Expanded Reimbursement and Access for REZZAYO

    https://www.businesswire.com/news/home/20231002893040/en

    BUSINESSWIRE
    02 Oct 2023
    Share Share
    Melinta Announces Commercial Availability of REZZAYO™ (rezafungin for injection)
    Melinta Announces Commercial Availability of REZZAYO™ (rezafungin for injection)

    https://www.businesswire.com/news/home/20230731503214/en

    BUSINESSWIRE
    31 Jul 2023
    Share Share
    Melinta secures $142M BARDA deal to target pediatric and 'biothreat' indications
    Melinta secures $142M BARDA deal to target pediatric and 'biothreat' indications

    https://endpts.com/melinta-secures-142m-barda-deal-to-target-pediatric-indications-for-antibiotics/

    Nicole DeFeudis ENDPTS
    10 Jul 2023
    Share Share
    Melinta Therapeutics Partners with BARDA to Advance Two FDA-Approved Antibiotics
    Melinta Therapeutics Partners with BARDA to Advance Two FDA-Approved Antibiotics

    https://www.businesswire.com/news/home/20230710869070/en

    BUSINESSWIRE
    10 Jul 2023
    Share Share
    Melinta Therapeutics and Xediton Pharmaceuticals Announce Licensing Agreement
    Melinta Therapeutics and Xediton Pharmaceuticals Announce Licensing Agreement

    https://www.businesswire.com/news/home/20230515005032/en

    BUSINESSWIRE
    15 May 2023
    Share Share
    FDA panel recommends rezafungin as new Candida treatment
    FDA panel recommends rezafungin as new Candida treatment

    https://www.businesswire.com/news/home/20230125005605/en/Cidara-Therapeutics-and-Melinta-Therapeutics-Announce-FDA-Advisory-Committee-Recommends-Approval-of-Rezafungin-for-the-Treatment-of-Candidemia-and-Invasive-Candidiasis

    BUSINESSWIRE
    26 Jan 2023
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search